Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(25.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 2(1)
N/A(1)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07092410Phase 4Withdrawn

Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib

Role: lead

NCT07346365Not ApplicableNot Yet Recruiting

Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent

Role: collaborator

NCT06394479Completed

Long-term Results After Bariatric Surgery in Type 1 Diabetes Patients

Role: collaborator

NCT03035188Phase 2Completed

Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma

Role: lead

NCT01900327Phase 3Terminated

Neoadjuvant Treatment in Resectable Pancreatic Cancer

Role: collaborator

NCT01315548Completed

Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses

Role: collaborator

NCT01728168Completed

Prevalence of Food Allergies to Proteins From Different Legumes

Role: collaborator

All 7 trials loaded